Beam Therapeutics Inc. (BEAM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Beam Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Beam Therapeutics Inc. (BEAM) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $2.6B. It trades at $28.78, up 15.58% today. Its overall quality score is 42 out of 100, ranked against the whole US market. 11 analysts' average target of $51.58 implies +79.2% from today's price. Kronos AI's 30-day forecast is +10.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $51.58 |
| Low – high | $26.00 – $80.00 |
| Analysts | 11 |
| Upside to average | +79.2% |
Kronos AI 30-day forecast
| Expected close | $27.58 (+10.8%) |
| Likely range | +7.4% … +23.1% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 19 |
| Solvency | 52 |
| Growth | 55 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator